Arvinas

pay deal hand over cash licensing transaction money

Pharma

Rigel snags Veppanu license from Pfizer, Arvinas for $85M

The deal includes up to $320 million in future milestone payments plus tiered royalties on Veppanu sales.

Zoey Becker May 12, 2026 11:35am

A photo finish at a horse race with both horses crossing the finish line

Pfizer, Arvinas' breast cancer med wins FDA approval

May 1, 2026 3:50pm

baton

Arvinas commercial chief John Northcott steps down

Jan 17, 2025 10:46am